Janux Therapeutics, Inc. (JANX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $44.74M | +15.5% |
| 2024 | $38.73M | +7.4% |
| 2023 | $36.06M | -16.7% |
| 2022 | $43.27M | +220.6% |
| 2021 | $13.50M | +46.2% |
| 2020 | $9.23M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $44.74M | +15.5% |
| 2024 | $38.73M | +7.4% |
| 2023 | $36.06M | -16.7% |
| 2022 | $43.27M | +220.6% |
| 2021 | $13.50M | +46.2% |
| 2020 | $9.23M | — |